 Jesse Davidson
Concepts (219)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiopulmonary Bypass | 16 | 2025 | 217 | 7.850 |
Why?
| | Heart Defects, Congenital | 14 | 2025 | 905 | 4.290 |
Why?
| | Alkaline Phosphatase | 6 | 2019 | 144 | 2.570 |
Why?
| | Cardiac Surgical Procedures | 8 | 2024 | 609 | 2.310 |
Why?
| | Circulatory Arrest, Deep Hypothermia Induced | 3 | 2025 | 27 | 1.930 |
Why?
| | Biomarkers | 11 | 2024 | 4261 | 1.510 |
Why?
| | Fontan Procedure | 2 | 2025 | 187 | 1.310 |
Why?
| | Endothelin-1 | 2 | 2022 | 181 | 1.150 |
Why?
| | Postoperative Complications | 9 | 2024 | 2950 | 1.140 |
Why?
| | Acute Kidney Injury | 3 | 2022 | 869 | 1.130 |
Why?
| | Infant | 23 | 2025 | 10023 | 1.130 |
Why?
| | Swine | 7 | 2025 | 828 | 1.090 |
Why?
| | Heart Arrest | 3 | 2020 | 406 | 1.000 |
Why?
| | Kynurenine | 3 | 2024 | 103 | 0.980 |
Why?
| | Tryptophan | 3 | 2024 | 175 | 0.940 |
Why?
| | Infant, Newborn | 14 | 2025 | 6399 | 0.900 |
Why?
| | Adenosine | 2 | 2018 | 255 | 0.890 |
Why?
| | Mucins | 1 | 2025 | 75 | 0.870 |
Why?
| | Renal Circulation | 1 | 2025 | 75 | 0.870 |
Why?
| | Neurodevelopmental Disorders | 2 | 2025 | 223 | 0.860 |
Why?
| | Matrix Metalloproteinase 8 | 1 | 2023 | 8 | 0.800 |
Why?
| | Citrulline | 1 | 2024 | 46 | 0.800 |
Why?
| | Prospective Studies | 14 | 2024 | 7994 | 0.790 |
Why?
| | Length of Stay | 6 | 2025 | 1339 | 0.790 |
Why?
| | Delirium | 1 | 2025 | 105 | 0.780 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2023 | 41 | 0.770 |
Why?
| | Arginine | 1 | 2024 | 238 | 0.750 |
Why?
| | Gastrointestinal Tract | 1 | 2025 | 207 | 0.740 |
Why?
| | Cerebrovascular Circulation | 1 | 2025 | 289 | 0.730 |
Why?
| | Heart Bypass, Right | 1 | 2022 | 17 | 0.720 |
Why?
| | Oxylipins | 1 | 2022 | 47 | 0.700 |
Why?
| | Infant, Newborn, Diseases | 1 | 2023 | 113 | 0.700 |
Why?
| | Lung | 3 | 2025 | 4089 | 0.700 |
Why?
| | Fetal Diseases | 1 | 2023 | 193 | 0.680 |
Why?
| | Amino Acids | 1 | 2025 | 521 | 0.670 |
Why?
| | Lower Extremity | 1 | 2025 | 440 | 0.660 |
Why?
| | Arrhythmias, Cardiac | 2 | 2020 | 355 | 0.640 |
Why?
| | Heart Diseases | 1 | 2023 | 341 | 0.620 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2024 | 387 | 0.610 |
Why?
| | Kidney | 2 | 2025 | 1495 | 0.610 |
Why?
| | Oxygen | 1 | 2025 | 984 | 0.610 |
Why?
| | Proteome | 1 | 2024 | 515 | 0.600 |
Why?
| | Metabolomics | 3 | 2021 | 724 | 0.600 |
Why?
| | Nitric Oxide | 1 | 2024 | 894 | 0.580 |
Why?
| | Interleukin-1 Receptor-Like 1 Protein | 1 | 2019 | 22 | 0.570 |
Why?
| | Coronary Care Units | 1 | 2018 | 27 | 0.570 |
Why?
| | Blood Proteins | 1 | 2020 | 230 | 0.560 |
Why?
| | Endotoxemia | 1 | 2019 | 86 | 0.550 |
Why?
| | Transcriptome | 1 | 2025 | 1036 | 0.550 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2019 | 122 | 0.540 |
Why?
| | Endotoxins | 1 | 2019 | 218 | 0.540 |
Why?
| | Aortic Coarctation | 1 | 2019 | 78 | 0.540 |
Why?
| | 5'-Nucleotidase | 1 | 2018 | 49 | 0.530 |
Why?
| | Humans | 37 | 2025 | 144667 | 0.500 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2018 | 580 | 0.490 |
Why?
| | Case-Control Studies | 5 | 2025 | 3603 | 0.490 |
Why?
| | Ventricular Remodeling | 1 | 2019 | 275 | 0.490 |
Why?
| | Calcitonin | 2 | 2013 | 27 | 0.490 |
Why?
| | Gene Expression Regulation | 1 | 2025 | 2591 | 0.470 |
Why?
| | Postoperative Care | 2 | 2021 | 286 | 0.460 |
Why?
| | Protein Precursors | 2 | 2013 | 136 | 0.460 |
Why?
| | Adenosine Monophosphate | 1 | 2016 | 86 | 0.460 |
Why?
| | Heart Ventricles | 4 | 2024 | 751 | 0.460 |
Why?
| | Tandem Mass Spectrometry | 1 | 2018 | 565 | 0.450 |
Why?
| | Ventricular Function, Left | 1 | 2019 | 536 | 0.450 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2018 | 287 | 0.450 |
Why?
| | Cardiotonic Agents | 2 | 2012 | 94 | 0.440 |
Why?
| | Sepsis | 3 | 2017 | 643 | 0.420 |
Why?
| | Female | 22 | 2025 | 78304 | 0.420 |
Why?
| | Male | 23 | 2025 | 72431 | 0.410 |
Why?
| | C-Reactive Protein | 2 | 2013 | 420 | 0.410 |
Why?
| | Glipizide | 1 | 2013 | 6 | 0.400 |
Why?
| | Treatment Outcome | 9 | 2025 | 11735 | 0.400 |
Why?
| | Cardiovascular Surgical Procedures | 1 | 2013 | 30 | 0.390 |
Why?
| | Octreotide | 1 | 2013 | 23 | 0.390 |
Why?
| | Sulfonylurea Compounds | 1 | 2013 | 51 | 0.380 |
Why?
| | Magnetic Resonance Imaging | 2 | 2025 | 3888 | 0.380 |
Why?
| | Brain | 1 | 2025 | 2934 | 0.370 |
Why?
| | Matrix Metalloproteinase 7 | 2 | 2023 | 25 | 0.360 |
Why?
| | Dysbiosis | 2 | 2024 | 187 | 0.360 |
Why?
| | Cardiac Output, Low | 1 | 2012 | 53 | 0.350 |
Why?
| | Thoracic Surgical Procedures | 1 | 2012 | 95 | 0.330 |
Why?
| | Purines | 2 | 2022 | 187 | 0.320 |
Why?
| | Hypoxia | 3 | 2024 | 1193 | 0.320 |
Why?
| | Child | 12 | 2025 | 22600 | 0.320 |
Why?
| | Heart Failure | 1 | 2024 | 2324 | 0.320 |
Why?
| | Child, Preschool | 8 | 2025 | 11790 | 0.320 |
Why?
| | Vasodilator Agents | 1 | 2012 | 329 | 0.310 |
Why?
| | Animals | 10 | 2025 | 37948 | 0.310 |
Why?
| | Predictive Value of Tests | 3 | 2025 | 2117 | 0.310 |
Why?
| | Cohort Studies | 4 | 2025 | 5957 | 0.300 |
Why?
| | Palliative Care | 3 | 2024 | 1011 | 0.290 |
Why?
| | Kinetics | 3 | 2018 | 1602 | 0.280 |
Why?
| | Postoperative Period | 2 | 2022 | 351 | 0.280 |
Why?
| | Hypoglycemia | 1 | 2013 | 479 | 0.270 |
Why?
| | Metabolome | 2 | 2021 | 385 | 0.260 |
Why?
| | Inflammation | 2 | 2022 | 2870 | 0.250 |
Why?
| | Age Factors | 3 | 2025 | 3329 | 0.240 |
Why?
| | Myocardial Contraction | 2 | 2025 | 288 | 0.230 |
Why?
| | Sus scrofa | 1 | 2025 | 64 | 0.220 |
Why?
| | Volunteers | 1 | 2025 | 39 | 0.220 |
Why?
| | Proteomics | 2 | 2023 | 1183 | 0.220 |
Why?
| | Sphingosine | 1 | 2025 | 45 | 0.220 |
Why?
| | Cardiac Output | 1 | 2025 | 179 | 0.210 |
Why?
| | Lysophospholipids | 1 | 2025 | 78 | 0.210 |
Why?
| | Mitochondria, Heart | 1 | 2025 | 101 | 0.210 |
Why?
| | Quality Improvement | 2 | 2025 | 1287 | 0.210 |
Why?
| | Organ Specificity | 1 | 2025 | 311 | 0.210 |
Why?
| | Fatty Acids, Volatile | 1 | 2024 | 60 | 0.210 |
Why?
| | Myocardial Reperfusion Injury | 1 | 2025 | 139 | 0.200 |
Why?
| | Language Development | 1 | 2024 | 59 | 0.200 |
Why?
| | Tissue Inhibitor of Metalloproteinase-1 | 1 | 2023 | 26 | 0.200 |
Why?
| | Perfusion | 1 | 2025 | 249 | 0.200 |
Why?
| | Blood Flow Velocity | 1 | 2025 | 419 | 0.200 |
Why?
| | Critical Care | 2 | 2021 | 695 | 0.190 |
Why?
| | Morbidity | 1 | 2024 | 322 | 0.190 |
Why?
| | Exercise Tolerance | 1 | 2025 | 282 | 0.190 |
Why?
| | Regional Blood Flow | 1 | 2025 | 513 | 0.190 |
Why?
| | Calcitonin Gene-Related Peptide | 2 | 2013 | 40 | 0.190 |
Why?
| | Animals, Newborn | 1 | 2025 | 890 | 0.190 |
Why?
| | Serotonin | 2 | 2024 | 294 | 0.180 |
Why?
| | Extracellular Matrix Proteins | 1 | 2023 | 156 | 0.180 |
Why?
| | Prostaglandins | 1 | 2022 | 94 | 0.180 |
Why?
| | Exercise Test | 1 | 2025 | 626 | 0.180 |
Why?
| | Analysis of Variance | 2 | 2016 | 1301 | 0.180 |
Why?
| | Oxygen Consumption | 1 | 2025 | 717 | 0.180 |
Why?
| | Time Factors | 3 | 2019 | 7140 | 0.180 |
Why?
| | Models, Animal | 1 | 2023 | 393 | 0.170 |
Why?
| | Niacinamide | 1 | 2021 | 87 | 0.160 |
Why?
| | Methionine | 1 | 2021 | 162 | 0.160 |
Why?
| | Preoperative Period | 1 | 2020 | 149 | 0.160 |
Why?
| | Heart Function Tests | 1 | 2019 | 59 | 0.150 |
Why?
| | Pulmonary Veins | 1 | 2020 | 104 | 0.150 |
Why?
| | Extracellular Matrix | 1 | 2023 | 560 | 0.150 |
Why?
| | International Classification of Diseases | 1 | 2020 | 147 | 0.150 |
Why?
| | Time | 1 | 2019 | 86 | 0.140 |
Why?
| | Chromatography, Liquid | 1 | 2020 | 444 | 0.140 |
Why?
| | Heart Transplantation | 1 | 2025 | 674 | 0.140 |
Why?
| | Matrix Metalloproteinases | 1 | 2019 | 95 | 0.140 |
Why?
| | Surgical Procedures, Operative | 1 | 2021 | 272 | 0.140 |
Why?
| | Adolescent | 6 | 2025 | 22409 | 0.130 |
Why?
| | Rewarming | 1 | 2018 | 21 | 0.130 |
Why?
| | Risk Factors | 4 | 2021 | 10796 | 0.130 |
Why?
| | Gene Expression Profiling | 1 | 2025 | 1766 | 0.130 |
Why?
| | GPI-Linked Proteins | 1 | 2018 | 81 | 0.130 |
Why?
| | Pilot Projects | 1 | 2023 | 1886 | 0.130 |
Why?
| | Mass Spectrometry | 1 | 2020 | 743 | 0.130 |
Why?
| | Hospital Mortality | 2 | 2018 | 1033 | 0.120 |
Why?
| | Cardiac Catheterization | 1 | 2020 | 557 | 0.120 |
Why?
| | Hospitalization | 2 | 2025 | 2446 | 0.120 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2019 | 392 | 0.120 |
Why?
| | Gastrointestinal Microbiome | 1 | 2024 | 771 | 0.120 |
Why?
| | Cognition | 1 | 2025 | 1263 | 0.120 |
Why?
| | Liver | 1 | 2025 | 1889 | 0.120 |
Why?
| | Extracellular Space | 1 | 2016 | 119 | 0.120 |
Why?
| | Solubility | 1 | 2016 | 236 | 0.120 |
Why?
| | Respiration, Artificial | 2 | 2018 | 710 | 0.120 |
Why?
| | Chi-Square Distribution | 1 | 2016 | 524 | 0.110 |
Why?
| | Coronary Thrombosis | 1 | 2015 | 25 | 0.110 |
Why?
| | Cytokines | 1 | 2023 | 2045 | 0.110 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1537 | 0.100 |
Why?
| | Databases, Factual | 1 | 2020 | 1494 | 0.100 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 1 | 2015 | 94 | 0.100 |
Why?
| | Intensive Care Units, Pediatric | 2 | 2017 | 288 | 0.100 |
Why?
| | Cattle | 1 | 2016 | 975 | 0.100 |
Why?
| | Liver Function Tests | 1 | 2013 | 105 | 0.100 |
Why?
| | Prognosis | 2 | 2019 | 4312 | 0.090 |
Why?
| | Intubation | 1 | 2012 | 7 | 0.090 |
Why?
| | Statistics, Nonparametric | 1 | 2013 | 427 | 0.090 |
Why?
| | Infusions, Intravenous | 1 | 2013 | 422 | 0.090 |
Why?
| | Logistic Models | 2 | 2020 | 2114 | 0.090 |
Why?
| | Algorithms | 1 | 2020 | 1844 | 0.090 |
Why?
| | Linear Models | 1 | 2013 | 845 | 0.080 |
Why?
| | ROC Curve | 1 | 2012 | 618 | 0.080 |
Why?
| | Retrospective Studies | 4 | 2021 | 17149 | 0.070 |
Why?
| | Intubation, Intratracheal | 1 | 2012 | 323 | 0.070 |
Why?
| | Severity of Illness Index | 1 | 2017 | 2922 | 0.070 |
Why?
| | Risk Assessment | 1 | 2018 | 3729 | 0.070 |
Why?
| | Myocardial Infarction | 1 | 2015 | 1209 | 0.060 |
Why?
| | Kynurenic Acid | 1 | 2024 | 17 | 0.050 |
Why?
| | Food Intolerance | 1 | 2024 | 3 | 0.050 |
Why?
| | Inpatients | 1 | 2025 | 547 | 0.040 |
Why?
| | Citalopram | 1 | 2020 | 32 | 0.040 |
Why?
| | Electrophysiological Phenomena | 1 | 2019 | 59 | 0.040 |
Why?
| | Mechanical Phenomena | 1 | 2019 | 81 | 0.040 |
Why?
| | Intestinal Mucosa | 1 | 2024 | 675 | 0.040 |
Why?
| | Odds Ratio | 1 | 2020 | 1076 | 0.030 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2019 | 248 | 0.030 |
Why?
| | Vasoconstrictor Agents | 1 | 2017 | 144 | 0.030 |
Why?
| | Adult | 1 | 2020 | 40489 | 0.030 |
Why?
| | Survival Rate | 1 | 2021 | 2089 | 0.030 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2015 | 56 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2021 | 915 | 0.030 |
Why?
| | Subtilisins | 1 | 1994 | 9 | 0.030 |
Why?
| | Hemodynamics | 1 | 2019 | 1113 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2025 | 4539 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2017 | 1268 | 0.030 |
Why?
| | Golgi Apparatus | 1 | 1994 | 99 | 0.030 |
Why?
| | Incidence | 1 | 2021 | 2892 | 0.030 |
Why?
| | Lysosomes | 1 | 1994 | 128 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2025 | 5967 | 0.030 |
Why?
| | Endosomes | 1 | 1994 | 140 | 0.020 |
Why?
| | Tissue Plasminogen Activator | 1 | 2015 | 244 | 0.020 |
Why?
| | Blood Pressure | 1 | 2019 | 1766 | 0.020 |
Why?
| | Fibrinolytic Agents | 1 | 2015 | 290 | 0.020 |
Why?
| | Membrane Glycoproteins | 1 | 1994 | 496 | 0.020 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2015 | 496 | 0.020 |
Why?
| | Antibodies, Monoclonal | 1 | 2015 | 1505 | 0.020 |
Why?
| | Mice | 1 | 2025 | 18261 | 0.020 |
Why?
| | United States | 1 | 2021 | 16018 | 0.010 |
Why?
| | Young Adult | 1 | 2020 | 14122 | 0.010 |
Why?
| | Immunologic Techniques | 1 | 1994 | 38 | 0.010 |
Why?
| | Furin | 1 | 1994 | 13 | 0.010 |
Why?
| | Cell Compartmentation | 1 | 1994 | 52 | 0.010 |
Why?
| | Cytoplasm | 1 | 1994 | 257 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 1994 | 2136 | 0.000 |
Why?
| | Molecular Sequence Data | 1 | 1994 | 2909 | 0.000 |
Why?
| | Cell Line | 1 | 1994 | 2821 | 0.000 |
Why?
| | Rats | 1 | 1994 | 5570 | 0.000 |
Why?
|
|
Davidson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|